(Q38994795)

English

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

scientific article published on 24 January 2017

Statements

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial (English)
Eftychia E Psarelli
Derek A O'Reilly
Jonathan Wadsley
Roopinder Gillmore
Gary William Middleton
Sebastian Cummins
Richard Jackson
European Study Group for Pancreatic Cancer

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit